Epstein Secrets

f percent FREE PSA may not be pos ible when the value for TOTAL PSA is in the low mammal range. These gu delines are for assays performed using the Roche E602 immunoassay syS em.(8/2015;V8.0) TESTOSTERONE, TOT.,S. TNP 193.0-740.0 ng/dL 296.0 101/27/2016 Test Not Performed: Specimen rejected for t

f the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE TNP Not Estab. ng/mL Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. 0.70 101/27/2016 NOTE: Results cannot be interpre

f percent FREE PSA may not be possible when the value for TOTAL PSA is in the low normal range. These guidelines are for assays performed using the Roche E170 immunoassay system.(02/2012;v5) TESTOSTERONE, TOT.,S. 296.0 193.0-740.0 ng/dL 112.3 LO 10/27/2015 TESTOSTERONE, BIOAVAIL. 183.8 72.0-46

the presence or absence of malignant disease. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE 0.33 Not Estab. ng/mL I 0.31 10/27/201S BioReference Laboratories, Inc. Elmwood Park, NJ 07407 James Weisberger M.D. Page 3 of S Laboratory Director Prin

ng prostate cancer by need NOTE: Calculation of percent FREE PSA may not be pos TOTAL PSA is in the low normal range. These gu performed using the Roche E6192 immunoassay sys e_ ,.. ...„._ (>or=70 yrs) 64.5% 40.8% 29.7% 15.8% e biopsy ible when the value for elines are for assays m.(8/20

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics). Not Estab. ng/mL to moderate or marked of the obtained used I 0.33 ¶01/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate

cancer by need :e NOTE: Calculation of percent FREE PSA may not be post TOTAL PSA is in the low normal range. These guidelines performed using the Roche E602 immunoassay sys TESTOSTERONE, TOT.,S. TOP Test Not Pe-formed: Specimen rejected for testing due hemolysis. 193.0.740.0 ng/dL to moderate o

th different assay methods or kits cannot be interchangeably. ASSAY INFORMATION: Method Electrocheedluninescence Immunoassay (Roche Diagnostics). Not Estab. ng/mi. to moderate or marked of the obtained used 1 0.33 101/27/2016 % FREE PSA TNP FREE PSA RISK ASSESSMENT The probability of prostate